A Randomized, Double-blind, Single and Multiple Ascending Dose Escalation, Placebo-controlled Clinical Trial to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection in Healthy Male Volunteers

Trial Profile

A Randomized, Double-blind, Single and Multiple Ascending Dose Escalation, Placebo-controlled Clinical Trial to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs VVZ 149 (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; First in man
  • Acronyms P1VVZ149IV
  • Sponsors Vivozon
  • Most Recent Events

    • 16 Aug 2017 Results published in the Journal of Clinical Pharmacology.
    • 24 Dec 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 31 Jul 2013 New source identified and integrated: Clinical Research Information Service (CriS) - Republic of Korea record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top